Xenon Pharmaceuticals Inc. · NASDAQ:XENE
Kenney Christopher John sold 7,068 Xenon Pharmaceuticals Inc. shares (Form 4)
Traded Aug 28, 2026 · Filed Aug 31, 2026
On Aug 28, 2026, Kenney Christopher John (Chief Medical Officer) sold 7,068 Xenon Pharmaceuticals Inc. shares at an average US$60.25 for US$426K under a trading plan, leaving 2 shares. Filed Aug 31, 2026 (Form 4).
- Sold
- 7,068 shares
- Price
- US$60.25 average (US$60.17 to US$60.98)
- Value
- US$426K
- Holding after
- 2 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | Common Shares | Sale | 6,368 | US$60.17 | 702 | Direct |
| Aug 28, 2026 | Common Shares | Sale | 700 | US$60.98 | 2 | Direct |